This is especially relevant for tirzepatide dosing , where the escalation steps are larger and side effects at each new dose can be more pronounced
In a recent study, tirzepatide achieved greater reductions in HbA1c levels compared to other commonly used diabetes medications
On average, participating members experienced virtually no weight gain (-0.1%) four months after discontinuing a GLP-1, compared to an estimated average of 6-7% weight gain from clinical trial data
For renal safety, Rybelsus can be used in patients with an eGFR greater than 30 mL/min, while metformin is contraindicated when eGFR drops below 30 and requires dose reduction between 30-45 mL/min
Jim, who started his journalism career as a Tokyo-based reporter for The Associated Press and U.S
The Penn group mentioned above will be studying semaglutide for OUD in combination with methadone or buprenorphine